Full Text View
Tabular View
No Study Results Posted
Related Studies
Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia
This study is currently recruiting participants.
Study NCT00537953   Information provided by Centro de Investigaciones Bioclínicas de la Fundación Fader
First Received: September 28, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cutaneous Leihmaniasis
Additional conditions recognized in this trial
Leishmaniasis
Leishmaniasis, Cutaneous
More general conditions related to this trial
Mastigophora Infections
Parasitic Diseases
Protozoan Infections
Sarcomastigophora Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
Miltefosine , meglumine antimoniate
Additional drug interventions recognized in this trial
Meglumine antimoniate
Miltefosine
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Centro de Investigaciones Bioclínicas de la Fundación Fader


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services